Univariable and multivariable HR for time to VS and time to first VF after suppression for 1377 subjects
| UnivariableHR(95% CI)VS | Univariable HR(95% CI)VF | Multivariable*aHR(95% CI)VS | Multivariable*aHR(95% CI)VF# | |
| OS-born status | 1.42 (1.23 to 1.64) | 0.64 (0.50 to 0.84) | 1.01 (0.86 to 1.17) | 0.93 (0.71 to 1.21) |
| OS-born ATRAS | 1.69 (1.25 to 2.29) | 0.26 (0.11 to 0.63) | 0.83 (0.60 to 1.41) | 0.93 (0.37 to 2.35) |
| OS-born Non-ATRAS | 1.36 (1.17 to 1.60) | 0.74 (0.56 to 0.97) | 1.05 (0.89 to 1.23) | 0.93 (0.70 to 1.22) |
| AUS-born (referent) | 1.00 | 1.00 | 1.00 | 1.00 |
| *Multivariable models adjusted for OS-born status, site type (GP, tertiary referral centre, sexual health clinic), period of ART initiation (<1997, 1997–2007, 2008+), HCB/HCV coinfection, CD4 cell count (cells/mm3), Viral load (copies/mL) and age at treatment initiation. #n=1344 for VF model. | ||||
aHR, adjusted HR; ART, antiretroviral therapy; ATRAS, Australian Temporary Residents Access Study; AUS, Australian; GP, specialist general practitioner; HCB, hepatitis B status; HCV, hepatitis C status; HR, unadjusted HR; OS, overseas-born; VF, virological failure; VS, virological suppression.